The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Osteonecrosis of the Jaw in a Patient on Denosumab
Open accessAbstract
Osteonecrosis of the jaws (ONJ) clinically presents as exposed, necrotic bone in the maxilla or mandible of at least eight week duration, with or without the presence of pain, infection, or previous trauma in a patient who has not received radiation to the jaws (1–3). Although necrotic bone exposure has been reported in the jaws of a variety of patients not receiving bisphosphonates (BPs;4–9), the number of BP related ONJ cases has continued to steadily increase since the first report in 2003 (10). To date, a direct causal relationship between BP use and ONJ has not been established (11,12). However, many retrospective and prospective analyses have identified cases of ONJ where BP therapy, especially the more potent intravenous preparations, was the only consistent variable, strongly suggesting that BPs play a significant role in ONJ pathophysiology (13–24). Potential mechanisms underlying bisphosphonate related osteonecrosis of the jaws (BRONJ) pathophysiology have generated great debate in the literature (25,26). It is not surprising that many hypotheses attempt to explain the unique localization of BRONJ exclusively to the jaws, including altered bone remodeling, angiogenesis inhibition, constant microtrauma, soft tissue BP toxicity, and bacterial infection (15,18,25,27–29). Importantly, ONJ incidence correlation with BP potency suggests that inhibition of osteoclast function and differentiation might be a key factor in the pathophysiology of the disease. Currently other inhibitors of osteoclast differentiation and function are entering the pharmacologic armamentarium for the treatment of diseases with increased bone turnover. The association of these new therapies with ONJ is uncertain. We report a case of ONJ in a patient receiving Denosumab, a human RANKL monoclonal antibody currently in clinical trials for the treatment of osteoporosis, primary and metastatic bone cancer, giant cell tumor, and rheumatoid arthritis (30–33).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Marx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Pathology and genetics of tumours of soft tissue and bone
Fletcher, C. D. �., Unni, K. K., & Mertens, F. (2002) · Medical Entomology and Zoology · Cited by 2,073
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Marx, R. E., Sawatari, Y., Fortin, M., & Broumand, V. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.07.010 · Cited by 1,648
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030897 · Cited by 1,347
Ruggiero, S. L., Dodson, T. B., Assael, L. A., Landesberg, R., Marx, R. E., & Mehrotra, B. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.01.009 · Cited by 1,328
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
Woo, S.-B., Hellstein, J. W., & Kalmar, J. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00009 · Cited by 1,252
Denosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
Bamias, A., Kastritis, E., Bamia, C., Moulopoulos, L. A., Melakopoulos, I., Bozas, G., Koutsoukou, V., Gika, D., Anagnostopoulos, A., Papadimitriou, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8670 · Cited by 1,149
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
Cellular and molecular mechanisms of action of bisphosphonates
Rogers, M. J., Gordon, S., Benford, H. L., Coxon, F. P., Luckman, S. P., Monkkonen, J., & Frith, J. C. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2961::aid-cncr12>3.0.co;2-l · Cited by 977
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035295 · Cited by 854
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040305 · Cited by 771
Osteonecrosis of the Jaw and Bisphosphonates
(2005) · New England Journal of Medicine · doi:10.1056/nejm200507073530120 · Cited by 744
Osteoclasts: What Do They Do and How Do They Do It?
Teitelbaum, S. L. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060834 · Cited by 730
Marx, R. E., Cillo, J. E., & Ulloa, J. J. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.08.003 · Cited by 720
Brown, J. P., Prince, R. L., Deal, C., Recker, R. R., Kiel, D. P., de Gregorio, L. H., Hadji, P., Hofbauer, L. C., Álvaro-Gracia, J. M., Wang, H., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0809010 · Cited by 610
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586
Khosla, S. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.01.054 · Cited by 564
Fizazi, K., Lipton, A., Mariette, X., Body, J.-J., Rahim, Y., Gralow, J. R., Gao, G., Wu, L., Sohn, W., & Jun, S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2146 · Cited by 533
Ruggiero, S. L., Fantasia, J., & Carlson, E. (2006) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2006.06.004 · Cited by 507
Ruggiero, S. L., Dodson, T. B., Assael, L. A., Landesberg, R., Marx, R. E., & Mehrotra, B. (2009) · Australian Endodontic Journal · doi:10.1111/j.1747-4477.2009.00213.x · Cited by 505
Body, J.-J., Facon, T., Coleman, R. E., Lipton, A., Geurs, F., Fan, M., Holloway, D., Peterson, M. C., & Bekker, P. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1933 · Cited by 490
Bisphosphanates and Oral Cavity Avascular Bone Necrosis
Migliorati, C. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.99.132 · Cited by 480
The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
Allen, M. R., & Burr, D. B. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.01.007 · Cited by 451
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity
Shipman, C. M., Rogers, M. J., Apperley, J. F., Russell, R. G. G., & Croucher, P. I. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2713086.x · Cited by 398
Lipton, A., Steger, G. G., Figueroa, J., Alvarado, C., Solal-Celigny, P., Body, J.-J., de Boer, R., Berardi, R., Gascon, P., Tonkin, K. S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8604 · Cited by 389
The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals
Jung, A., Bisaz, S., & Fleisch, H. (1973) · Calcified Tissue Research · doi:10.1007/bf02547227 · Cited by 381
Rab GTPases in vesicular transport
Zerial, M., & Stenmark, H. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90130-i · Cited by 381
Dr. Coxon, F. P., Helfrich, M. H., Van't Hof, R., Sebti, S., Ralston, S. H., Hamilton, A., & Rogers, M. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1467 · Cited by 361
Zervas, K., Verrou, E., Teleioudis, Z., Vahtsevanos, K., Banti, A., Mihou, D., Krikelis, D., & Terpos, E. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06230.x · Cited by 297
Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases
Bagan, J. V., Murillo, J., Jimenez, Y., Poveda, R., Milian, M. A., Sanchis, J. M., Silvestre, F. J., & Scully, C. (2005) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2004.00269.x · Cited by 266
Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy
Sato, M., & Grasser, W. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050107 · Cited by 264
Murakami, H., Takahashi, N., Sasaki, T., Udagawa, N., Tanaka, S., Nakamura, I., Zhang, D., Barbier, A., & Suda, T. (1995) · Bone · doi:10.1016/s8756-3282(95)00150-6 · Cited by 218
Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: A case–control study
Tse, L. F., Wong, K. C., Kumta, S. M., Huang, L., Chow, T. C., & Griffith, J. F. (2008) · Bone · doi:10.1016/j.bone.2007.08.038 · Cited by 201
Possible Association between Diabetes and Bisphosphonate-Related Jaw Osteonecrosis
Khamaisi, M., Regev, E., Yarom, N., Avni, B., Leitersdorf, E., Raz, I., & Elad, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2036 · Cited by 200
Weitzman, R., Sauter, N., Eriksen, E. F., Tarassoff, P. G., Lacerna, L. V., Dias, R., Altmeyer, A., Csermak-Renner, K., McGrath, L., Lantwicki, L., et al. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.12.005 · Cited by 185
Thomas, D. M., & Skubitz, K. M. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832c951d · Cited by 183
Avascular necrosis of the jaws: risk factors in metastatic cancer patients
Tarassoff, P., & Csermak, K. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2003.09.001 · Cited by 175
RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases
Baud’huin, M., Lamoureux, F., Duplomb, L., Rédini, F., & Heymann, D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7104-0 · Cited by 170
Rogers, M. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0024-1 · Cited by 164
Lipton, A., Steger, G. G., Figueroa, J., Alvarado, C., Solal-Celigny, P., Body, J. J., de Boer, R., Berardi, R., Gascon, P., Tonkin, K. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5234 · Cited by 162
Morgan, T., Atkins, G. J., Trivett, M. K., Johnson, S. A. S., Kansara, M., Schlicht, S., Slavin, J., Simmons, P. J., Dickinson, I. C., Powell, G., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62959-8 · Cited by 136
Osteonecrosis of the Jaw: More Research Needed
Shane, E. J., Goldring, S. R., Christakos, S., McKee, M. D., Eisman, J. A., Silverman, S. L., & Pendrys, D. G. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060712 · Cited by 96
Pozzi, S., Marcheselli, R., Sacchi, S., Baldini, L., Angrilli, F., Pennese, E., Quarta, G., Stelitano, C. C., Caparrotti, G., Luminari, S., et al. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600977690 · Cited by 92
Mortensen, M., Lawson, W. B., & Montazem, A. H. (2007) · The Laryngoscope · doi:10.1097/01.mlg.0000240885.64568.9e · Cited by 84
Tat, S. K., Padrines, M., Theoleyre, S., Couillaud-Battaglia, S., Heymann, D., Redini, F., & Fortun, Y. (2006) · Bone · doi:10.1016/j.bone.2006.03.016 · Cited by 63
Bisphosphonates and jaw osteonecrosis: The UAMS experience
Clarke, B. M., Boyette, J. R., Vural, E. A., Suen, J. Y., Anaissie, E. J., & Stack, B. C. (2007) · Otolaryngology · doi:10.1016/j.otohns.2006.11.008 · Cited by 51
Lewiecki, E. M. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832ca41c · Cited by 45
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
Geusens, P. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s3333 · Cited by 44
Osteonecrosis Related to Intraosseous Anesthesia: Report of a Case
Woodmansey, K. F., White, R. K., & He, J. (2008) · Journal of Endodontics · doi:10.1016/j.joen.2008.11.002 · Cited by 29
Clinical applications of RANK‐ligand inhibition
Romas, E. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01732.x · Cited by 28
Novel Approaches in the Management of Myeloma-Related Skeletal Complications
Reddy, G. K., Mughal, T. I., & Roodman, G. D. (2006) · Supportive Cancer Therapy · doi:10.3816/sct.2006.n.026 · Cited by 8
Cited by
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O'Ryan, F. (2014) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2014.04.031 · Cited by 2,905
Self-citationKhan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2405 · Cited by 1,353
Self-citationDenosumab and bisphosphonates: Different mechanisms of action and effects
Baron, R., Ferrari, S., & Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2010.11.020 · Cited by 715
Hellstein, J. W., Adler, R. A., Edwards, B., Jacobsen, P. L., Kalmar, J. R., Koka, S., Migliorati, C. A., & Ristic, H. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0108 · Cited by 363
Nicolatou-Galitis, O., Schiødt, M., Mendes, R. A., Ripamonti, C., Hope, S., Drudge-Coates, L., Niepel, D., & Van den Wyngaert, T. (2019) · Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.09.008 · Cited by 361
Metadata
- Authors
- Aghaloo, T. L., Felsenfeld, A. L., & Tetradis, S.
- Venue
- Journal of Oral and Maxillofacial Surgery
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 68
- Issue
- 5
- Pages
- 959-963
- ISSN
- 0278-2391 (ISSN-L)
- OpenAlex
- W2090174147
- Cited by
- 275
- References
- 56
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.